#astria therapeutics

1 story

#bcrx #biocryst #business #finance #hereditary angioedema #nasdaq #navenibart #orladeyo #rare disease drugs

BioCryst Turns First Profit
BioCryst becomes profitable with Orladeyo and plans rare disease acquisitions.
Yahoo Finance · 1m